Ovitrelle

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

6 competitors in Oocyte

#DrugCompanyPhaseTrials

1

Decapeptyl

SSheba Medical Center

Preclinical

12

Dual Trigger

WWeill Medical College of Cornell University

Preclinical

13

Ovitrelle

Merck & Co.

Preclinical

14

In Vitro Maturation

NNorthwell Health

Preclinical

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Ovarian Stimulation2 trials

Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation

Withdrawn·Ferring·Phase 2·NCT05571111

Comparison of Triggers in Double Ovarian Stimulation (DuoStim).

Unknown status·IInstituto Bernabeu·Phase 4·NCT05321511·165 enrolled

Breast Cancer1 trial

Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

Completed·UUniversity Hospital, Ghent·Phase 4·NCT03495609·33 enrolled

Ovarian Reserve1 trial

hCG Priming in Women With Low Ovarian Reserve

Completed·RRigshospitalet, Denmark·Phase 4·NCT04643925·20 enrolled

Treatment1 trial

Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders

Unknown status·HHadassah Medical Organization·N/A·NCT01205009·100 enrolled

Oocyte1 trial

Follicle Size and Oocyte Development

Completed·SSheba Medical Center·N/A·NCT03660813·200 enrolled

2 more indications

ESS1 trial

EXpression PRofile Endometrium Samples Study

Terminated·Merck & Co.·Phase 4·NCT01210144·27 enrolled

Frozen Embryo Transfer1 trial

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Recruiting·FFundacion Clinic per a la Recerca Biomédica·Phase 4·NCT06896617·334 enrolled

Details

Drug Info

Related News